Campuses

As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >

Advantages

Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >

Highlights

Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >
Company

Proteinea


Business incubator Genopole Entreprises – 4, rue Pierre Fontaine
91000 EVRY-COURCOURONNES – FRANCE
Téléphone : +20 1 122 998 088
Email : hello@proteinea.com

Mahmoud Eljendy : Président directeur général
Web Site >
Proteinea - Genopole's company Proteinea - Genopole's company

Booster#Industrial Biotech #Biomanufacturing / Pharmaceutical Services

  • Recombinant protein production
  • Next-gen bio manufacturing platform
  • Synthetic biology
  • Metabolic engineering
  • Bioproduction
  • Bio-sourced molecules
  • Bioeconomics / Sustainable development

Field of Activity


Production as a service (PaaS) platform capable of producing recombinant proteins & enzymes cheaper and on a scale

Background

Proteinea is an insect-based biotechnology startup. Proteinea defines the economics of building with biology by offering a one-step process to produce high-quality recombinant proteins of interest in an affordable, environmentally sustainable, and predictable manner.

Description of the Products / Services / Technology

Proteinea is integrating biology with engineering and molecular sciences to build the next-gen bio-manufacturing platform. Proteinea has developed a patent-pending technology, called InsectaPro, for using insects as mini-bioreactors to produce recombinant proteins on a scale at a significantly lower cost. It’s robust, scalable, and significantly more advantageous than conventional bioreactors.

Proteinea has a production as a service model (PaaS), in which the company secures partnerships with companies to sustainably produce (biobased and biodegradable) proteins/enzymes of interest in order to significantly reduce their environmental impact and produce at a large-scale and competitive cost coupled with high quality.

Customer references / Collaborations / Highlights

Proteinea joined IndieBio, the largest biotech accelerator, in during the winter/spring 2021 cohort.

Collaborations Sought

One of the areas Proteinea is aiming to collaborate is in the vaccine production field.

  • Further informations

    4 Patents

    15 Staff members

    Strengths:
    Proteinea is offering a one-step process to produce high-quality recombinant proteins of interest in an affordable, environmentally sustainable, and predictable manner.

    Innovation Assets:
    Using insects as mini-bioreactors to produce recombinant proteins on a scale at a significantly lower cost.

     

Share
Genopole’s Companies

#Industrial Biotech


In same field

FABMID - entreprise génopolitaine

FABMID

Fabmid develop a cutting-edge DNA vector to reduce the cost and improve efficiency of cell and gene therapy

Discover
Altar - entreprise génopolitaine

Altar

Altar is a specialist in the conception and operation of automated fluidic continuous culture systems for adaptive laboratory evolution and the development of microbial strains for industry.

Discover
Yposkesi - Genopole's Company

Yposkesi

YposKesi is the first French company to develop and manufacture gene and cell therapy products for rare diseases.

Discover
Watchfrog Laboratory - Genopole's company

WatchFrog

WatchFrog markets in vivo biotechnological solutions for environmental risk assessment and the evaluation of the therapeutic, toxic or pollutant potential of all types of chemical, cosmetic or pharmaceutical compounds.

Discover
Pymabs - Genopole's Company

Pymabs

R & D services in the field of transient expression of recombinant proteins in plants.

Discover
Pharming - Genopole's company - Logo 2021

PHARMING

Pharming specializes in the production of recombinant proteins in transgenic rabbit milk.

Discover
Glowee - Genopole's company

Glowee

Glowee is a cleantech startup developing a disruptive lighting technology based on bioluminescence (the natural light-producing property of certain living organisms).

Discover
Global Bioenergies - Genopole's company

Global Bioenergies

Global Bioenergies is developing a process to convert renewable resources into hydrocarbons through fermentation.

Discover
ABOLIS - entreprise génopolitaine

Abolis Biotechnologies

Development of custom-order microorganisms able to produce molecules of interest in health, nutrition, cosmetics, chemistry and agriculture.

Discover
View all >
With support